Evidence map›Paper›PMID 26401700›Full record

ArticleJournal of Alzheimer's disease : JAD2015

APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.

Xiaoying Tang, Dominic Holland, Anders M Dale, Michael I Miller, Alzheimer's Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Impact ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A profile of brain reserve in adults at genetic risk of Alzheimer's disease.Alzheimer's & dementia (Amsterdam, Netherlands) · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xiaoying TangCenter for Imaging Science, Johns Hopkins University, Baltimore, MD, USA.
Dominic HollandDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Anders M DaleDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Michael I MillerCenter for Imaging Science, Johns Hopkins University, Baltimore, MD, USA.
Alzheimer's Disease Neuroimaging Initiative
Johns Hopkins University · USUniversity of California San Diego · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
X-LINKED ADRENOLEUKODYSTROPHYP41RR015241 · NCRR · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI MC DONALD, JOHN · 2001 to 2011
$18.5M
Validation of Structural/Functional MRI LocalizationR01EB000975 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI BARTA, PATRICK E, MILLER, MICHAEL I · 2002 to 2012
$3.0M
3D Shape Analysis for Computational AnatomyR01EB008171 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI MILLER, MICHAEL I · 2009 to 2012
$2.0M
"MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies"K01AG030514 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARMICHAEL, OWEN T. · 2008 to 2012
$495k
Canadian Institutes of Health ResearchNCRR NIH HHS P41 RR015241NCRR NIH HHS P41 RR15241NIA NIH HHS K01 AG030514NIA NIH HHS P30 AG010129NIA NIH HHS U01 AG024904NIBIB NIH HHS R01 EB000975NIBIB NIH HHS R01 EB008171
6 · The paper itself

Abstract

This paper examines how age intervenes in the effects of APOE ɛ4 allele on the volume and shape morphometrics of the hippocampus and the amygdala in mild cognitive impairment (MCI) and Alzheimer's disease. We evaluate the structural morphological differences between ɛ4 carriers and non-carriers in two age-dependent subgroups; younger than 75 years (Young-Old) and older than 80 years (Very-Old). While we show that the four structures of interest atrophy significantly in the ɛ4 carriers, relative to the non-carriers, of the Young-Old group, this effect is not observed in their Very-Old counterparts. The structures in the right hemisphere are found to be more affected by the APOE genotype than those in the left hemisphere and we identify the relevant regions in which significant atrophy occurs to be parts of the basolateral, centromedial, and lateral nucleus subregions of the amygdala and the CA1 and subiculum subregions of the hippocampus. We also observe that the APOE genotype only affects MCI patients that deteriorated to dementia within 3 years while leaving their "non-converting" counterparts unaffected.

Indexed as

AgedAged, 80 and overAgingAlzheimer DiseaseAmygdalaApolipoprotein E4Cognitive DysfunctionCohort StudiesDisease ProgressionFemaleFollow-Up StudiesFunctional LateralityHeterozygoteHippocampusHumansMagnetic Resonance ImagingApolipoprotein E4Age interventionAlzheimer’s diseaseamygdalaapolipoprotein Econversionhippocampusmild cognitive impairmentshape morphometrics

Identifiers

PMID26401700
PMCPMC5479937
OpenAlexW1114273137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.